[The use of helium-neon laser in drug-resistant cardiac arrhythmias].
Out of 85 patients with cardiac arrhythmias in the presence of chronic coronary heart disease, 28 who were resistant to ethacisine and allapinine were included into the study. They had frequent and persistent arrhythmias. The patients were divided into 2 groups: (1) the patients receiving intravenous He-Ne laser therapy in combination with one of the above drugs; (n = 17) and (2) those taking He-Ne laser therapy alone (n = 11). The efficacy of the therapies were controlled by 24-hour monitoring. An antiarrhythmic effect was more frequently observed when He-Ne laser was combined with one of the above drugs than when it was given alone (67.4 and 36.3%, respectively).
Gel'fgat
E B
EB
Abdullaev
R F
RF
Babaev
Z M
ZM
Musabekov
S Sh
SSh
D000157:Aconitine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy*; D003327:Coronary Disease / Q000150:complications; D004351:Drug Resistance; D006371:Helium; D006801:Humans; D053685:Laser Therapy; D008875:Middle Aged; D009356:Neon; D010640:Phenothiazines / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; D006371:Helium; D009356:Neon; C051402:allapinin; C046818:ethacizine; D000157:Aconitine
Primenenie geliĭ-neonovogo lazera pri ustoĭchivykh k lekarstvennoĭ terapii aritmiiakh serdtsa.